Patents Assigned to The Hospital Authority
  • Patent number: 7445776
    Abstract: There is provided a method for growing human intervertebral cells. Disc tissue is surgically removed from a normal disc of a patient, the cells expanded by feeding with a cell stimulant such as a growth factor, or a cytokine or a bioactive agent to form monolayer primary cell cultures on a plastic mesh such as a nylon mesh. In the case of a growth factor, fetal bovine serum is preferred as it improves cell proliferation and production of appropriate extracellular matrix components. In another aspect of this invention, the monolayer primary cell cultures are seeded in alginate or agarose and fed again with the cell stimulant until three-dimensional cell cultures are formed. The cells are recovered from the alginate or agarose or from monolayer cultures. Re-implantation is carried out using bioresorbable carriers or cell suspensions.
    Type: Grant
    Filed: June 13, 2005
    Date of Patent: November 4, 2008
    Assignee: Charlotte-Mecklenburg Hospital Authority
    Inventors: Edward Nathaniel Hanley, Jr., Helen Elizabeth Gruber
  • Patent number: 7439020
    Abstract: The present invention provides methods of predicting a pre-disposition of HBV-infected individuals to develop hepatacellular carcinoma (HCC).
    Type: Grant
    Filed: December 20, 2004
    Date of Patent: October 21, 2008
    Assignees: The Chinese University of Hong Kong, The Hospital Authority
    Inventors: Jao Yiu Joseph Sung, Lik Yuen Chan, Kwok Wing Stephen Tsui, Kwong Sak Leung, Shu Kam Tony Mok, Angeline Bartholomeusz, Wai Yee Nancy Leung, Kin Hong Lee
  • Patent number: 7288551
    Abstract: The present invention is directed to preservation solutions for storing and perfusing a heart intended for transplantation to a patient requiring such implant. It was found that when cyclosporin is added to the preservation solution for to: (1) preserve the mitochondrial function which it does by maintaining adenosine triphosphate (“ATP”) levels, and (2) to block apoptosis and prevent programmed cell death. Therefore, the preservation of the mitochondrial function prevents necrosis while blocking prevents apoptosis.
    Type: Grant
    Filed: September 19, 2000
    Date of Patent: October 30, 2007
    Assignee: Charlotte-Mecklenburg Hospital Authority
    Inventor: Thomas N. Masters
  • Publication number: 20070203424
    Abstract: A breath condensate collection apparatus comprising a central chamber, a breath input assembly, a plunger assembly and a breath condensate collection port. The central chamber has inner and outer side walls with a coolant material sealed in between. The breath input assembly is disposed on the side of the central chamber in fluid communication with the chamber interior. The plunger assembly has a piston, slidably disposed in the chamber, and a handle extending from a first end of the chamber. The collection port is disposed at the second end of the central chamber in fluid communication with the interior of the chamber. Obstructive structures may be arranged in the chamber interior for increasing the surface area on which condensate may form. The apparatus may also include an outlet assembly that may be removed and replaced with a sampling well into which the condensate may be washed with a buffer solution.
    Type: Application
    Filed: May 1, 2007
    Publication date: August 30, 2007
    Applicant: The Charlotte-Mecklenburg Hospital Authority
    Inventor: Jeffrey Kline
  • Publication number: 20070123792
    Abstract: A method and system for detecting the presence of restriction to expired airflow in humans or animals by analyzing the expired capnogram and oxygram, as well as the geometric analysis of the real-time plot of the waveform that depicts the instantaneous ratio of CO2 to O2 (the carboxygram ratio). Airway obstructions causes an increase in the Q-angle between the slope of phase 11 and slope of phase III in the expired carboxygram. The diagnostic accuracy of the detection of airways obstruction is further enhanced by measuring the ratio of time spent in exhalation (Te) versus inhalation (Ti). The system uses the combination of an increased carboxygram Q-angle, and a prolonged Te/Ti to detect presence of airways obstruction.
    Type: Application
    Filed: November 17, 2005
    Publication date: May 31, 2007
    Applicant: Charlotte-Mecklenburg Hospital Authority d/b/a Carolinas Medical Center
    Inventor: Jeffrey Kline
  • Publication number: 20070100250
    Abstract: A diagnosis method for respiratory disease based on the separation of the expired airway phase in an exhaled breath from the alveolar phase, and a device to accomplish the method. The device includes a cartridge assembly and a disposable condensing chamber carried in a substantially enclosed housing. The cartridge assembly includes a disposable cartridge and a reusable control system that monitors a characteristic of gas passing through the cartridge to determine when to divert the exhaled breath to an exhaust outlet and when to divert the exhaled breath to the condensing chamber. The characteristic is selected as being representative of the transition from the expired airway phase to the alveolar phase. Also included are a refrigeration system, an auxiliary monitoring system for determining when a sufficient volume of gas has been produced, and a built-in analyzer.
    Type: Application
    Filed: November 29, 2006
    Publication date: May 3, 2007
    Applicant: The Charlotte-Mecklenburg Hospital Authority
    Inventor: Jeffrey Kline
  • Publication number: 20070078357
    Abstract: A method of determining the presence of pulmonary embolism is a postoperative patient using the carbox ratio of the patient prior to the surgical procedure and the carbox ratio of the patient after to the surgical procedure. The characteristics of the breath of the patient are obtained prior to a surgical procedure for a baseline and then afterwards if the patient has difficult breathing. The mean carbox ratios from the baseline and post-surgical data collections are then compared to non-invasively predict the likelihood that the patient has developed pulmonary embolism. A decrease in the carbox ratio of more than twenty-five percent (25%) represents an abnormal test and is consistent with possible pulmonary embolism. No change or an increase in the carbox ratio suggests the absence of pulmonary embolism.
    Type: Application
    Filed: November 6, 2006
    Publication date: April 5, 2007
    Applicant: Charlotte-Mecklenburg Hospital Authority d/b/a Carolinas Medical Center
    Inventor: Jeffrey Kline
  • Publication number: 20070073183
    Abstract: A diagnosis method for respiratory disease based on the separation of the expired airway phase in an exhaled breath from the alveolar phase, and a device to accomplish the method. The device includes a cartridge assembly and a disposable condensing chamber carried in a substantially enclosed housing. The cartridge assembly includes a disposable cartridge and a reusable control system that monitors a characteristic of gas passing through the cartridge to determine when to divert the exhaled breath to an exhaust outlet and when to divert the exhaled breath to the condensing chamber. The characteristic is selected as being representative of the transition from the expired airway phase to the alveolar phase. Also included are a refrigeration system, an auxiliary monitoring system for determining when a sufficient volume of gas has been produced, and a built-in analyzer.
    Type: Application
    Filed: November 29, 2006
    Publication date: March 29, 2007
    Applicant: The Charlotte-Mecklenburg Hospital Authority
    Inventor: Jeffrey Kline
  • Publication number: 20060259329
    Abstract: A system and method for determining the degree of abnormality of a vital sign of a patient by obtaining the clinical profile of said patient and determining the statistical difference between the vital sign of the patient and the vital signs of previously evaluated patients having similar clinical profiles. The vital signs of previously evaluated patients having similar clinical profiles are determined based on matching the attributes of the patent's clinical profile to the clinical profiles of previously evaluated patients. The statistical difference, and the patent's clinical profile may be exported to an electronic medical record system or printed in hard copy for inclusion in the patient's medial file.
    Type: Application
    Filed: November 22, 2005
    Publication date: November 16, 2006
    Applicant: CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITY D/B/A CAROLINAS MEDICAL CENTER
    Inventor: Jeffrey Kline
  • Patent number: 7101545
    Abstract: There is provided a method for growing human intervertebral cells. Disc tissue is surgically removed from a normal disc of a patient, the cells expanded by feeding with a cell stimulant such as a growth factor, or a cytokine or a bioactive agent to form monolayer primary cell cultures on a plastic mesh such as a nylon mesh. In the case of a growth factor, fetal bovine serum is preferred as it improves cell proliferation and production of appropriate extracellular matrix components. In another aspect of this invention, the monolayer primary cell cultures are seeded in alginate or agarose and fed again with the cell stimulant until three-dimensional cell cultures are formed. The cells are recovered from the alginate or agarose or from monolayer cultures. Re-implantation is carried out using bioresorbable carriers or cell suspensions.
    Type: Grant
    Filed: April 27, 2000
    Date of Patent: September 5, 2006
    Assignees: Charlotte-Mecklenburg Hospital Authority, Carolinas Medical Center
    Inventors: Edward Nathaniel Hanley, Jr., Helen Elizabeth Gruber
  • Publication number: 20060057601
    Abstract: The present invention provides methods of predicting a pre-disposition of HBV-infected individuals to develop hepatacellular carcinoma (HCC).
    Type: Application
    Filed: December 20, 2004
    Publication date: March 16, 2006
    Applicants: The Chinese University of Hong Kong, Hospital Authority
    Inventors: Jao Yiu Sung, Lik Chan, Kwok Wing Tsui, Kwong Leung, Shu Kam Mok, Angeline Bartholomeusz, Wai Yee Leung, Kin Lee
  • Publication number: 20060057670
    Abstract: The present invention provides methods of predicting a pre-disposition of HBV-infected individuals to develop hepatacellular carcinoma (HCC).
    Type: Application
    Filed: September 10, 2004
    Publication date: March 16, 2006
    Applicants: The Chinese University of Hong Kong, The Hospital Authority
    Inventors: Jao Yiu Sung, Lik Chan, Kwok Wing Tsui, Kwong Leung, Shu Kam Mok, Angeline Bartholomeusz, Wai Yee Leung, Kin Lee
  • Patent number: 6987127
    Abstract: Malignant melanoma cells spontaneously generate reactive oxygen species (ROS) that promote constitutive activation of the transcription factor nuclear factor-kB (NF-kB). Although antioxidants and inhibitors of NAD(P)H oxidases significantly reduce constitutive NF-kB activation and suppress cell proliferation, the nature of the enzyme responsible for ROS production in melanoma cells has not been determined. To address this issue, we now have characterized the source of ROS production in melanoma cells. ROS are generated by isolated, cytosol-free melanoma plasma membranes, with inhibition by NAD(P)H oxidase inhibitors. The p22phox, gp91phox and p67phox components of the human phagocyte NAD(P)H oxidase, and the 91phox homolog NOX4 were demon-strated in melanomas by RT-PCR and sequencing, and protein product for both p22phox and gp91phox were detected in cell membranes by immunoassay. Normal human epidermal melanocytes expressed only p22phox and NOX4.
    Type: Grant
    Filed: December 19, 2002
    Date of Patent: January 17, 2006
    Assignee: Charlotte-Mecklenburg Hospital Authority
    Inventor: Thomas Preston Kennedy
  • Publication number: 20050208614
    Abstract: A method for determining whether a subject has Gram negative bacterial pneumonia based on the presence of lipopolysaccharide in exhaled breath condensate collected from the subject. The collection devices utilized to collect exhaled breath condensate from both spontaneously breathing and mechanically ventilated subjects and the devices utilized to determine whether lipopolysaccharide is present in the collected exhaled breath condensate.
    Type: Application
    Filed: May 23, 2005
    Publication date: September 22, 2005
    Applicant: The Charlotte-Mecklenburg Hospital Authority
    Inventors: Jeffrey Kline, Jackeline Hernandez, John Watts
  • Publication number: 20050196868
    Abstract: A method for diagnosing and monitoring pulmonary hypertension using free hemoglobin, as well as surrogates for free hemoglobin, as markers for pulmonary hypertension. Bodily fluids, such as blood, serum, plasma, urine and/or breathe condensate may be collected and analyzed to determine the concentration of free hemoglobin or surrogates of free hemoglobin. The concentration indicates the presence or absence of pulmonary hypertension.
    Type: Application
    Filed: March 3, 2005
    Publication date: September 8, 2005
    Applicant: The Charlotte-Mecklenburg Hospital Authority
    Inventors: Jeffrey Kline, John Zagorski
  • Patent number: 6936048
    Abstract: The invention is a transvaginal ultrasound probe having an attached echogenic needle that is useful in the treatment of uterine fibroids. The echogenic needle has an echogenic surface near its tip that allows the physician to visualize its location using ultrasound imaging. In one embodiment, the needle has an active electrode at its distal end. The active electrode supplies radio frequency energy to a fibroids causing necrosis of the targeted fibroid or by destroying the fibroid's vascular supply. The radio frequency needle preferably has a safety device that shuts-off energy if the needle punctures the uterine wall. In a second embodiment, the needle has a cryogen supply tube and cryogen supply. This embodiment destroys fibroid tissue by freezing it or its vascular supply when the tissue comes in contact with the needle's frozen distal end. The invention further includes the method of using the ultrasound probe with the attached needle.
    Type: Grant
    Filed: January 16, 2003
    Date of Patent: August 30, 2005
    Assignee: Charlotte-Mecklenburg Hospital Authority
    Inventor: Bradley Shawn Hurst
  • Patent number: 6796949
    Abstract: This invention provides a sock containing a coating material such as a coloring agent or dye, applied to at least a portion of the interior surface of the sock for sensing pressure points on a patient's foot to which the sock is fitted. The sock is placed on the patient's foot to cover preferably the entire foot, but at least the bottom portion thereof. The sock is removed after being worn for a period of time, and in those areas of the foot susceptible to pressure points, the coating material transfers from the interior of the sock and adheres to the foot in those points. The present invention is particularly applicable to a person having diabetic neuropathic feet wherein portions of the foot may be insensitive to pressure and therefore must be protected against pressure sores.
    Type: Grant
    Filed: October 7, 2002
    Date of Patent: September 28, 2004
    Assignee: Charlotte-Mecklenburg Hospital Authority
    Inventor: James M. Horton
  • Patent number: 6793639
    Abstract: A pelvic splint for immobilizing and maintaining the annular integrity of the pelvis in the event of a pelvic ring fracture. The pelvic splint extends from about 5-10 cm above the iliac crest down to about the middle third of the thighs and substantially encircles the pelvis of the victim. The splint is then secured about the pelvis of the victim with two or more adjustable straps. The splint comprises a flexible casing having at least one pliable padding layer disposed therein and a plurality of flexible members individually disposed in pockets spaced apart about the casing. Once tightly secured around the pelvis by the adjustable straps, the splint conforms to the contours of the victim's pelvic area and stabilizes the pelvis by preventing lateral movement and constraining the pelvis in such a manner to preserve the annular integrity thereof. An associated method of stabilizing a pelvis is also disclosed.
    Type: Grant
    Filed: November 21, 2002
    Date of Patent: September 21, 2004
    Assignee: Charlotte-Mecklenburg Hospital Authority
    Inventors: Michael A. Gibbs, Michael Bosse, John Marx, Steven Colucciello, David Jacobs, Barbara Ozmar
  • Publication number: 20040171678
    Abstract: Dithiocarbamate, particularly tetraethylthiuram disulfide, and thiocarbamate anions strongly inhibit the growth of cancer cells of a variety of cell types. Such inhibitory effect is enhanced by heavy metal ions such as copper ions, cytokines and ceruloplasmin. A method is presented for using tetraethylthiuram disulfide to reduce tumor growth, and to potentiate the effect of other anticancer agents.
    Type: Application
    Filed: February 25, 2004
    Publication date: September 2, 2004
    Applicant: Charlotte-Mecklenburg Hospital Authority d/b/a Carolinas Medical Center
    Inventor: Thomas Preston Kennedy
  • Publication number: 20040162500
    Abstract: A diagnosis method for respiratory disease based on the separation of the expired airway phase in an exhaled breath from the alveolar phase, and a device to accomplish the method. The device includes a cartridge assembly and a disposable condensing chamber carried in a substantially enclosed housing. The cartridge assembly includes a disposable cartridge and a reusable control system that monitors a characteristic of gas passing through the cartridge to determine when to divert the exhaled breath to an exhaust outlet and when to divert the exhaled breath to the condensing chamber. The characteristic is selected as being representative of the transition from the expired airway phase to the alveolar phase. Also included are a refrigeration system, an auxiliary monitoring system for determining when a sufficient volume of gas has been produced, and a built-in analyzer.
    Type: Application
    Filed: February 13, 2004
    Publication date: August 19, 2004
    Applicant: The Charlotte-Mecklenburg Hospital Authority
    Inventor: Jeffrey A. Kline